| Item | Value |
|---|---|
| DrugBank ID | DB00799 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 36 |
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | acne (disease) | TxGNN Knowledge Graph |
| 2 | parapsoriasis | TxGNN Knowledge Graph |
| 3 | psoriasis | TxGNN Knowledge Graph |
| 4 | acne (disease) | TxGNN Knowledge Graph |
| 5 | parapsoriasis | TxGNN Knowledge Graph |
| 6 | psoriasis | TxGNN Knowledge Graph |
| 7 | acne (disease) | TxGNN Knowledge Graph |
| 8 | parapsoriasis | TxGNN Knowledge Graph |
| 9 | psoriasis | TxGNN Knowledge Graph |
| 10 | acne (disease) | TxGNN Knowledge Graph |
| 11 | parapsoriasis | TxGNN Knowledge Graph |
| 12 | psoriasis | TxGNN Knowledge Graph |
| 13 | acne (disease) | TxGNN Knowledge Graph |
| 14 | parapsoriasis | TxGNN Knowledge Graph |
| 15 | psoriasis | TxGNN Knowledge Graph |
| 16 | acne (disease) | TxGNN Knowledge Graph |
| 17 | parapsoriasis | TxGNN Knowledge Graph |
| 18 | psoriasis | TxGNN Knowledge Graph |
| 19 | acne (disease) | TxGNN Knowledge Graph |
| 20 | parapsoriasis | TxGNN Knowledge Graph |
| 21 | psoriasis | TxGNN Knowledge Graph |
| 22 | acne (disease) | TxGNN Knowledge Graph |
| 23 | parapsoriasis | TxGNN Knowledge Graph |
| 24 | psoriasis | TxGNN Knowledge Graph |
| 25 | acne (disease) | TxGNN Knowledge Graph |
| 26 | parapsoriasis | TxGNN Knowledge Graph |
| 27 | psoriasis | TxGNN Knowledge Graph |
| 28 | acne (disease) | TxGNN Knowledge Graph |
| 29 | parapsoriasis | TxGNN Knowledge Graph |
| 30 | psoriasis | TxGNN Knowledge Graph |
| 31 | acne (disease) | TxGNN Knowledge Graph |
| 32 | parapsoriasis | TxGNN Knowledge Graph |
| 33 | psoriasis | TxGNN Knowledge Graph |
| 34 | acne (disease) | TxGNN Knowledge Graph |
| 35 | parapsoriasis | TxGNN Knowledge Graph |
| 36 | psoriasis | TxGNN Knowledge Graph |
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.